De Langavant Boris Cleret, Kefleyesus Amaniel, Peron Julien, Glehen Olivier, Galan Alexandre, Benzerdjeb Nazim, Villeneuve Laurent, Kepenekian Vahan, Rousset Pascal, Grange Rémi
Department of General Surgery and Surgical Oncology, CHU Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
CICLY, EMR 3738, Lyon 1 University, Lyon, France.
Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-18022-0.
In patients with colorectal cancer and peritoneal metastases (CRC-PM), the completeness of cytoreductive surgery (CRS) is crucial. However, a history of moderate (Prior Surgical Score, PSS-2) or extensive (PSS-3) abdominal surgery may compromise the exploration, increasing the risk of undetected CRC-PM. This retrospective monocentric study investigated the value of preoperative peritoneal magnetic resonance imaging (MRI) in identifying potentially occult lesions in patients with PSS-2/3 CRC-PM scheduled for CRS.
Consecutive patients with pathologically confirmed CRC-PM and PSS-2/3, selected for radical treatment, were included. All underwent preoperative peritoneal MRI ≤ 7 days before CRS, between January 2015 and December 2020. MRI, surgical, and pathological reports were reviewed focusing on seven anatomical sites of interest (perihepatic, pelvic, retroperitoneum, abdominal wall, anastomosis, inguinal canal, and cardiophrenic space).
Overall, 248 patients were included; 242 (97.6%) underwent complete CRS (CC-0). Among them, 212 (85.5%) were PSS-2 and 36 (14.5%) PSS-3. The sensitivity, specificity, and accuracy of MRI in detecting lesions were, respectively, 65%, 91%, and 82% (perihepatic region); 53%, 81%, and 63% (pelvis); 41%, 91%, and 69% (retroperitoneum); 46%, 91%, and 79% (abdominal wall); and 44%, 98%, and 74% (anastomotic sites). In the inguinal canal and cardiophrenic space, preoperative MRI led to ten resections in ten patients, with neoplastic cells detected in eight cases (80%).
Preoperative peritoneal MRI demonstrated good specificity and a promising negative predictive value (NPV) but modest sensitivity in detecting lesions across seven anatomically challenging regions. Further studies are warranted to better define its added value over standard preoperative imaging protocols.
在结直肠癌伴腹膜转移(CRC-PM)患者中,细胞减灭术(CRS)的彻底性至关重要。然而,中度(既往手术评分,PSS-2)或广泛(PSS-3)腹部手术史可能会影响探查,增加未被发现的CRC-PM风险。这项回顾性单中心研究调查了术前腹膜磁共振成像(MRI)在识别计划接受CRS的PSS-2/3 CRC-PM患者中潜在隐匿性病变的价值。
纳入连续的经病理证实为CRC-PM且PSS-2/3、选择进行根治性治疗的患者。所有患者在2015年1月至2020年12月期间于CRS前≤7天接受术前腹膜MRI检查。回顾MRI、手术及病理报告,重点关注七个感兴趣的解剖部位(肝周、盆腔、腹膜后、腹壁、吻合口、腹股沟管及心膈角区)。
共纳入248例患者;242例(97.6%)接受了完整的CRS(CC-0)。其中,212例(85.5%)为PSS-2,36例(14.5%)为PSS-3。MRI检测病变的敏感性、特异性和准确性分别为:肝周区域65%、91%和82%;盆腔53%、81%和63%;腹膜后41%、91%和69%;腹壁46%、91%和79%;吻合口部位44%、98%和74%。在腹股沟管和心膈角区,术前MRI导致10例患者进行了切除,其中8例(80%)检测到肿瘤细胞。
术前腹膜MRI显示出良好的特异性和有前景的阴性预测值(NPV),但在检测七个解剖学上具有挑战性的区域的病变时敏感性一般。有必要进行进一步研究以更好地确定其相对于标准术前成像方案的附加价值。